emoxypine succinate has been researched along with hematoxylin in 1 studies
| Studies (emoxypine succinate) | Trials (emoxypine succinate) | Recent Studies (post-2010) (emoxypine succinate) | Studies (hematoxylin) | Trials (hematoxylin) | Recent Studies (post-2010) (hematoxylin) |
|---|---|---|---|---|---|
| 310 | 60 | 130 | 2,228 | 25 | 918 |
| Protein | Taxonomy | emoxypine succinate (IC50) | hematoxylin (IC50) |
|---|---|---|---|
| Chain E, Fibrin beta chain | Homo sapiens (human) | 9.328 | |
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 17.36 | |
| Mcl-1 | Homo sapiens (human) | 3.4393 | |
| MPI protein | Homo sapiens (human) | 26.374 | |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 20.0467 | |
| Vif | Human immunodeficiency virus 1 | 0.46 | |
| Tat | Human immunodeficiency virus 1 | 11.696 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 0.46 | |
| large T antigen | Betapolyomavirus macacae | 4.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maskin, SS; Petrov, VI; Ponomarev, ÉA; Strepetov, NN | 1 |
1 other study(ies) available for emoxypine succinate and hematoxylin
| Article | Year |
|---|---|
[Pharmacological neuroprotection against brain damage in ischemiai/reperfusion experiment].
Topics: Animals; Brain; Drug Combinations; Drug Evaluation, Preclinical; Eosine Yellowish-(YS); Flavin Mononucleotide; Glycine; Hematoxylin; Heme; Hemostasis; Immunohistochemistry; Inosine Diphosphate; Male; Necrosis; Neurons; Neuroprotective Agents; Niacinamide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Picolines; Rats; Rats, Inbred Strains; Reperfusion Injury; Succinates; TNF-Related Apoptosis-Inducing Ligand | 2011 |